TactiFlex Paroxysmal Atrial Fibrillation IDE Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 355 participants.
Also called NCT04356040
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 355 participants
- Sponsor
- Registry
-
NCT04356040
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Canada, Czechia, Germany, Hong Kong SAR China, Italy, Netherlands, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT04356040. Non-randomized; no masking; primary purpose treatment. Start 2020-06-29 (actual); primary completion 2022-07-01 (actual). Results posted on 2023-10-31.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TactiFlex Paroxysmal Atrial Fibrillation IDE Trial
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- TactiFlex SE
- Intervention (Device)
- TactiFlex SE - High Standard Power
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct04356040- Content hash
a2ef9ba20bed7ee9bf7d08532771fb8642284119cc437eed1936256d3a6eeccd